Cover Image
市場調查報告書

P2D Bioscience:產品平台分析

P2D Bioscience - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256026
出版日期 內容資訊 英文 34 Pages
訂單完成後即時交付
價格
Back to Top
P2D Bioscience:產品平台分析 P2D Bioscience - Product Pipeline Review - 2015
出版日期: 2015年11月18日 內容資訊: 英文 34 Pages
簡介

P2D Bioscience 是開發,提供遺傳性罕見疾病治療藥的製藥公司。該公司的產品有普瑞德威利症候群、額顳葉失智症、注意力不足過動症障礙等,中樞神經系統障礙的治療藥。

本報告提供P2D Bioscience 的治療藥開發平台的現狀及最新更新的各開發階段比較分析、企業和研究機關的最新新聞和發表、正在開發的治療藥、治療藥的評估、後期階段及中止的計劃相關資訊等。

P2D Bioscience的基本資料

  • P2D Bioscience概要
  • 主要資訊
  • 企業資料

P2D Bioscience :R&D概要

  • 主要的治療範圍

P2D Bioscience :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

P2D Bioscience :開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式

P2D Bioscience :開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

P2D Bioscience :藥物簡介

  • betahistine hydrochloride
  • 0.02
  • IDT
  • PD-2005
  • PD-2007
  • PD-2015
  • PD-2016
  • PD-2024
  • PD-3766
  • PD-4048
  • PD-4074
  • Drug for Attention Deficit Hyperactivity Disorder

P2D Bioscience :開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

P2D Bioscience :暫停中的計劃

P2D Bioscience :總公司和子公司的所在地

P2D Bioscience :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07746CDB

Summary

Global Markets Direct's, 'P2D Bioscience - Product Pipeline Review - 2015', provides an overview of the P2D Bioscience's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of P2D Bioscience's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of P2D Bioscience including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of P2D Bioscience's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the P2D Bioscience's pipeline products

Reasons to buy

  • Evaluate P2D Bioscience's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of P2D Bioscience in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the P2D Bioscience's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of P2D Bioscience and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of P2D Bioscience
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of P2D Bioscience and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • P2D Bioscience Snapshot
    • P2D Bioscience Overview
    • Key Information
    • Key Facts
  • P2D Bioscience - Research and Development Overview
    • Key Therapeutic Areas
  • P2D Bioscience - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • P2D Bioscience - Pipeline Products Glance
    • P2D Bioscience - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • P2D Bioscience - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • P2D Bioscience - Drug Profiles
    • betahistine hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • 2E-2
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IDT
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PD-2005
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PD-2007
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PD-2015
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PD-2016
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PD-2024
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PD-3766
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PD-4048
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PD-4074
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Casin
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • P2D Bioscience - Pipeline Analysis
  • P2D Bioscience - Pipeline Products by Target
  • P2D Bioscience - Pipeline Products by Route of Administration
  • P2D Bioscience - Pipeline Products by Molecule Type
  • P2D Bioscience - Pipeline Products by Mechanism of Action
  • P2D Bioscience - Dormant Projects
  • P2D Bioscience - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • P2D Bioscience, Key Information
  • P2D Bioscience, Key Facts
  • P2D Bioscience - Pipeline by Indication, 2015
  • P2D Bioscience - Pipeline by Stage of Development, 2015
  • P2D Bioscience - Monotherapy Products in Pipeline, 2015
  • P2D Bioscience - Phase I, 2015
  • P2D Bioscience - Preclinical, 2015
  • P2D Bioscience - Discovery, 2015
  • P2D Bioscience - Pipeline by Target, 2015
  • P2D Bioscience - Pipeline by Route of Administration, 2015
  • P2D Bioscience - Pipeline by Molecule Type, 2015
  • P2D Bioscience - Pipeline Products by Mechanism of Action, 2015
  • P2D Bioscience - Dormant Developmental Projects,2015

List of Figures

  • P2D Bioscience - Pipeline by Top 10 Indication, 2015
  • P2D Bioscience - Pipeline by Stage of Development, 2015
  • P2D Bioscience - Monotherapy Products in Pipeline, 2015
  • P2D Bioscience - Pipeline by Top 10 Target, 2015
  • P2D Bioscience - Pipeline by Top 10 Molecule Type, 2015
  • P2D Bioscience - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top